Related Experiment Video
Updated: Jun 22, 2026

High-throughput Assay to Phenotype Salmonella enterica Typhimurium Association, Invasion, and Replication in Macrophages
Published on: August 11, 2014
Accelerated type III secretion system 2-dependent enteropathogenesis by a Salmonella enterica serovar enteritidis
Mrutyunjay Suar1, Balamurugan Periaswamy, Pascal Songhet
1Institute of Microbiology, D-BIOL, ETH Zürich, CH-8093 Zurich, Switzerland.
Abstract:
Salmonella enterica subsp. I serovars Typhimurium and Enteritidis are major causes of enteric disease. The pathomechanism of enteric infection by serovar Typhimurium has been studied in detail. Serovar Typhimurium employs two pathways in parallel for triggering disease, i.e., the "classical" pathway, triggered by type III secretion system 1 (TTSS-1), and the "alternative" pathway, mediated by TTSS-2. It had remained unclear whether these two pathways would also explain the enteropathogenesis of strains from other serovars. We chose the isolate P125109 of the epidemic serovar Enteritidis PT4/6, generated isogenic mutants, and studied their virulence. Using in vitro and in vivo infection experiments, a dendritic cell depletion strategy, and MyD88(-/-) knockout mice, we found that P125109 employs both the "classical" and "alternative" pathways for triggering mucosal inflammation. The "classical" pathway was phenotypically similar in serovar Typhimurium strain SL1344 and in P125109. However, the kinetics of the "alternative" pathway differed significantly. Via TTSS-2, P125109 colonized the gut tissue more efficiently and triggered mucosal inflammation approximately 1 day faster than SL1344 did. In conclusion, our data demonstrate that different Salmonella spp. can differ in their capacity to trigger mucosal inflammation via the "alternative" pathway in vivo.
Insights
Salmonella Enteritidis and Typhimurium cause enteric disease. This study shows Salmonella Enteritidis uses two pathways, similar to Typhimurium, but triggers inflammation faster via the alternative pathway (TTSS-2).
Area of Science:
- Microbiology
- Infectious Diseases
- Immunology
Background:
- Salmonella enterica serovars Typhimurium and Enteritidis are significant causes of human enteric illness.
- The molecular mechanisms of Salmonella Typhimurium pathogenesis, involving type III secretion systems (TTSS-1 and TTSS-2), are well-characterized.
- The role of these pathways in the pathogenesis of other Salmonella serovars remained unclear.
Purpose of the Study:
- To investigate the enteropathogenesis of Salmonella Enteritidis PT4/6 (isolate P125109).
- To determine if the classical (TTSS-1) and alternative (TTSS-2) pathways are involved in Salmonella Enteritidis virulence.
- To compare the kinetics of inflammation triggered by Salmonella Enteritidis and Salmonella Typhimurium.
Main Methods:
- Generation of isogenic mutants of Salmonella Enteritidis P125109.
- In vitro and in vivo infection models.
- Dendritic cell depletion and MyD88 knockout mouse studies.
Main Results:
- Salmonella Enteritidis P125109 utilizes both TTSS-1 and TTSS-2 pathways to induce mucosal inflammation.
- The classical pathway function was comparable between Salmonella Enteritidis and Salmonella Typhimurium.
- The alternative pathway (TTSS-2) in Salmonella Enteritidis mediated faster gut colonization and inflammation induction compared to Salmonella Typhimurium.
Conclusions:
- Both classical and alternative pathways contribute to Salmonella Enteritidis enteropathogenesis.
- Salmonella species exhibit differential kinetics in triggering mucosal inflammation via the alternative pathway (TTSS-2).
- These findings highlight serovar-specific variations in Salmonella virulence mechanisms.
Related Concept Videos
Bacterial Gastroenteritis
Gram-negative Bacterial Protein Secretion Systems
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Translocation and Protein Secretion
Amebiasis
Regulation of Bacterial Virulence

